Literature DB >> 22078084

A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

Michael R Ringenbach1, Erin Banta, Melissa R Snyder, Timothy J Craig, Faoud T Ishmael.   

Abstract

Alpha-1-antitrypsin (A1AT) deficiency is a genetic disease characterized by low levels and/or function of A1AT protein. A1AT deficiency can result in the development of COPD, liver disease, and certain skin conditions. The disease can be diagnosed by demonstrating a low level of A1AT protein and genotype screening for S and Z mutations, which are the most common. However, there are many genetic variants in A1AT deficiency, and this screening may miss rarer cases, such as those caused by dysfunctional protein. We identified a patient with a previously unreported F/null phenotype that was missed by routine screening. This case highlights the wide variation in possible mutations, limitations in diagnostics, and the importance of combining clinical suspicion with measurement of protein levels, phenotypic analysis, and in appropriate cases expanded genetic analysis.

Entities:  

Year:  2011        PMID: 22078084      PMCID: PMC3229436          DOI: 10.1186/1710-1492-7-18

Source DB:  PubMed          Journal:  Allergy Asthma Clin Immunol        ISSN: 1710-1484            Impact factor:   3.406


  10 in total

1.  American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-10-01       Impact factor: 21.405

Review 2.  Clinical practice. Alpha1-antitrypsin deficiency.

Authors:  Edwin K Silverman; Robert A Sandhaus
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

3.  Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.

Authors:  Melissa R Snyder; Jerry A Katzmann; Malinda L Butz; Carmen Wiley; Ping Yang; D Brian Dawson; Kevin C Halling; W Edward Highsmith; Stephen N Thibodeau
Journal:  Clin Chem       Date:  2006-10-19       Impact factor: 8.327

Review 4.  Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

Authors:  Frederick J de Serres
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Deletion/frameshift mutation in the alpha 1-antitrypsin null allele, PI*QObolton.

Authors:  G C Fraizer; M Siewertsen; T R Harrold; D W Cox
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

6.  Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase.

Authors:  L Cook; J G Burdon; S Brenton; K R Knight; E D Janus
Journal:  Pathology       Date:  1996-08       Impact factor: 5.306

Review 7.  Alpha-1-antitrypsin associated panniculitis: the MS variant.

Authors:  Pedram Geraminejad; James R DeBloom; Hobart W Walling; Richard D Sontheimer; Marta VanBeek
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527

8.  Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease?

Authors:  G Beckman; N L Stjernberg; A Eklund
Journal:  Clin Genet       Date:  1984-06       Impact factor: 4.438

9.  Alpha-1 antitrypsin Null mutations and severity of emphysema.

Authors:  Laura Fregonese; Jan Stolk; Rune R Frants; Barbera Veldhuisen
Journal:  Respir Med       Date:  2008-03-18       Impact factor: 3.415

Review 10.  Alpha-1-antitrypsin deficiency panniculitis.

Authors:  Ricardo Valverde; Belén Rosales; Francisco Javier Ortiz-de Frutos; José Luis Rodríguez-Peralto; Pablo L Ortiz-Romero
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

  10 in total
  4 in total

1.  The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.

Authors:  Anna Ptasinski; Jacob Colello; Joseph Ptasinski; Gavin Barclay; Timothy Craig
Journal:  Allergy Asthma Proc       Date:  2021-11-01       Impact factor: 2.587

2.  The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote.

Authors:  Nicola Jane Sinden; Firas Koura; Robert Andrew Stockley
Journal:  BMC Pulm Med       Date:  2014-08-07       Impact factor: 3.317

3.  Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.

Authors:  Friedrich Kueppers; Mark D Andrake; Qifang Xu; Roland L Dunbrack; Joannah Kim; Christopher L Sanders
Journal:  BMC Med Genet       Date:  2019-07-15       Impact factor: 2.103

4.  Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.

Authors:  Friedrich Kueppers
Journal:  Respir Med Case Rep       Date:  2021-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.